From the hemp fields to Washington D.C., the cannabis industry faces more shifts in the year ahead.
Despite legalization disappointments from 2024, the cannabis industry is far from standing still as the calendar changes over to 2025.
A significant factor is that use of the plant continues to expand. And a key driver of that is hemp products. But the battle between federally legal hemp products and state-legal marijuana products will likely come to a truce of sorts.
The CEO of Seattle-based Cycling Frog put it succinctly to Green Market Report : “By this time next year, I don’t think we’re going to be having much conversation about the war between marijuana and hemp because every marijuana company is also going to be a hemp company.”
Additionally, integrating intoxicating hemp into legal cannabis channels could add $10 billion in revenue – a 30% increase over current levels, according to Morgan Paxhia, co-founder and managing partner at Poseidon.
That’s not the only shift cannabis operators will need to make, as consumer preferences are also shifting. Casual, on-the-go options are proving more popular for many post-pandemic – especially as wallets tighten. That means continued increases in sales of beverages, pre-rolls, gummies and vaporizers – and as a result more options from established operators, like Trulieve Cannabis Corp., are also making their way to dispensary shelves.
“Gen Z cannabis consumers are increasingly turning to vape pens over traditional flower,” said CCELL’s Nick Kovacevich, pointing to Headset data showing 37.9% of young consumers preferring vapes to flower’s 32.5%. Federal legalization efforts
While those trends will be key to growth in 2025, efforts to reschedule cannabis – or even fully legalize it – at the federal level continue to overshadow most other discussions. The administrative hearing granted by the Drug Enforcement Administration was pushed into this year, but bickering over the witness list continues.
Industry leaders, however, remain optimistic. TerrAscend’s executive chairman, Jason Wild, took it a step further, saying he doesn’t think the industry will wait for a DEA decision. TerrAscend is involved in a federal lawsuit asserting that the Dormant Commerce Clause has already effectively made cannabis legal, and […]

Ketamine shows promise for treatment-resistant PTSD in psychedelic-style therapy settings
[Imagen 3] Follow PsyPost on Google News A new study